About Us



MitoPower is developing MP-04, a small molecule that enhances mitochondrial function. MP-04 has shown promising results in improving cellular metabolism and reversing organ dysfunction in pre-clinical studies. MP-04 will initially be indicated for the treatment of patients with liver failure, including acute on chronic liver failure (ACLF).